IS4198A - Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða - Google Patents

Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða

Info

Publication number
IS4198A
IS4198A IS4198A IS4198A IS4198A IS 4198 A IS4198 A IS 4198A IS 4198 A IS4198 A IS 4198A IS 4198 A IS4198 A IS 4198A IS 4198 A IS4198 A IS 4198A
Authority
IS
Iceland
Prior art keywords
treatment
side effects
effects associated
extracellular hemoglobin
hemoglobin administration
Prior art date
Application number
IS4198A
Other languages
English (en)
Inventor
J. Gerber Michael
Original Assignee
Somatogen, Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somatogen, Inc filed Critical Somatogen, Inc
Publication of IS4198A publication Critical patent/IS4198A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IS4198A 1993-08-13 1994-08-04 Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða IS4198A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10613893A 1993-08-13 1993-08-13

Publications (1)

Publication Number Publication Date
IS4198A true IS4198A (is) 1995-02-14

Family

ID=22309699

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4198A IS4198A (is) 1993-08-13 1994-08-04 Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða

Country Status (8)

Country Link
US (1) US5750132A (is)
EP (2) EP0784983A3 (is)
JP (1) JPH09501441A (is)
AU (2) AU7194694A (is)
CA (1) CA2167716A1 (is)
IS (1) IS4198A (is)
NO (1) NO960545L (is)
WO (1) WO1995005167A2 (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE243040T1 (de) * 1994-03-28 2003-07-15 Baxter Int Therapeutische verwendung von hämoglobin in der behandlung einer blutgefässblockade
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
FR2809624B1 (fr) * 2000-05-31 2002-08-02 Centre Nat Rech Scient Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
CN102574901B (zh) * 2009-05-07 2016-08-03 埃玛里纳 新的血红蛋白及其用途
CN103781489B (zh) * 2011-09-06 2017-03-29 黄炳镠 用于基于血红蛋白的氧载体的口服递送

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
US4965065A (en) * 1986-04-29 1990-10-23 Bristol-Myers Squibb Company Gastroprotective process and compositions
US5043358A (en) * 1986-03-04 1991-08-27 Bristol-Myers Squibb Company Gastroprotective process
US4826811A (en) * 1986-06-20 1989-05-02 Northfield Laboratories, Inc. Acellular red blood cell substitute
EP0561245A1 (en) * 1987-05-16 1993-09-22 Somatogenetics International, Inc. Blood substitutes comprising recombinant hemoglobin
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
NL8901174A (nl) * 1989-05-10 1990-12-03 Het Hoofd Van De Afdeling Mili Hemoglobine-preparaat en gebruik daarvan.
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US5173426A (en) * 1989-10-06 1992-12-22 Yale University DNAs encoding genetically engineered low oxygen affinity mutants of human hemoglobin
US5478806A (en) * 1989-11-22 1995-12-26 Enzon, Inc. Enhancement of antitumor therapy with hemoglobin-based conjugates
NZ237827A (en) * 1990-04-16 1994-03-25 Strohtech Inc Pure globin chain or haem-binding fragment thereof and methods for its production
CA2098818A1 (en) * 1990-12-20 1992-06-21 Tim Townes Transgenic, cross-linked hemoglobin
US5295944A (en) * 1991-05-14 1994-03-22 Dana-Farber Cancer Institute Method for treating a tumor with ionizing radiation
WO1992020369A1 (en) * 1991-05-14 1992-11-26 Dana Farber Cancer Institute Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
US5624823A (en) * 1991-11-22 1997-04-29 The General Hospital Corporation DNA encoding procine interleukin-10

Also Published As

Publication number Publication date
AU7011098A (en) 1998-07-30
WO1995005167A2 (en) 1995-02-23
EP0717619A1 (en) 1996-06-26
NO960545D0 (no) 1996-02-12
NO960545L (no) 1996-02-29
EP0784983A3 (en) 2001-03-21
JPH09501441A (ja) 1997-02-10
WO1995005167A3 (en) 1995-04-13
EP0784983A2 (en) 1997-07-23
CA2167716A1 (en) 1995-02-23
US5750132A (en) 1998-05-12
AU7194694A (en) 1995-03-14

Similar Documents

Publication Publication Date Title
FI963482A0 (fi) Menetelmä hematopoieesin stimuloimiseksi hemoglobiinilla
FI970531A0 (fi) Veren rasvapitoisuutta alentavia 1,4-bentsotiatsepiini-1,1-dioksideja
DE69200166D1 (de) Hemodialyseverfahren.
DE69730513D1 (de) Subkutane sicherheitskatheter-anordnung
LV11615A (lv) Amidi ar arstnieciskam ipasibam
DE69431369D1 (de) Venenkanüle
DE69429905D1 (de) Puls - Monitor
NL194779B (nl) Gestabiliseerd vrijdragend patiÙnttafelstelsel.
EP0652018A3 (en) Device for protecting a transducer for biomedical hemodialysis lines.
DE69410520D1 (de) Behandlungsbehälter
DE69418007D1 (de) Behandlungsbehälter
FI971634A0 (fi) Neisseria-bakteereista peräisin olevia hemoglobiinireseptoreita
DE69318821D1 (de) Katheter zur Versorgung des Penis mit Medikamenten
NO911429D0 (no) Stoffbehandling.
KR960701628A (ko) 말초 정맥 투여용 영양 수액(Nutritional transfusion for peripheral vein administration)
IS4198A (is) Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
FI950984A (fi) Verkkopiste varustettuna siihen sisäänrakennetulla verkkolaitteella
ITTO930757A0 (it) Macchina per dialisi extracorporea.
NO911430D0 (no) Stoffbehandlingsmetode.
DE4499496T1 (de) Haltbarer Patientenstuhl
IS5324A (is) (S) 2-Metýlamínó-2-fenýl-n-bútýl 3,4,5-trímetoxý-bensóat, notkun þess til meðferðar á langvinnum sársauka
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
DE69638066D1 (de) Stabiles Blutersatzmittel mit polymerisiertem Hämoglobin
EG19223A (en) Therapeutic agents.